Rani Therapeutics Holdings (RANI) Cash from Operations (2020 - 2026)

Rani Therapeutics Holdings' Cash from Operations history spans 7 years, with the latest figure at 6500000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 20.24% to 6500000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 17065000.0, a 50.16% increase, with the full-year FY2025 number at 18714000.0, up 47.28% from a year prior.
  • Cash from Operations came in at 6500000.0 for Q1 2026, down from 286000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 286000.0 in Q4 2025, with the low at 14629000.0 in Q4 2022.
  • Historically, Cash from Operations has averaged 9321235.29 across 5 years, with a median of 9360000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: crashed 131.23% in 2022 and later soared 103.3% in 2025.
  • Year by year, Cash from Operations stood at 14629000.0 in 2022, then increased by 14.7% to 12478000.0 in 2023, then skyrocketed by 30.64% to 8655000.0 in 2024, then surged by 103.3% to 286000.0 in 2025, then tumbled by 2372.73% to 6500000.0 in 2026.
  • Business Quant data shows Cash from Operations for RANI at 6500000.0 in Q1 2026, 286000.0 in Q4 2025, and 5100000.0 in Q3 2025.